NanoViricides, Inc. (NNVC) income statement
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.19+0.03 (+2.59%)
Close on Nov 18, 2026Market cap $30.37MP/E –Yield –
NanoViricides, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -101.5%
Financial strength
- Current ratio
- 2.66
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 234.7%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.50
- Dividend yield
- –
See a number that looks wrong?